Marius König

Systemic and T cell‐associated responses to <scp>SARS‐CoV</scp>‐2 immunisation in gut inflammation (<scp>STAR SIGN</scp> study): effects of biologics on vaccination efficacy of the third dose of <scp>mRNA</scp> vaccines against <scp>SARS‐CoV</scp>‐2

Simon Woelfel, Joel Dütschler, Marius König et al. · Alimentary Pharmacology & Therapeutics · 2022 · 16 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

STAR SIGN study: Evaluation of COVID‐19 vaccine efficacy against the SARS‐CoV‐2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease

Simon Woelfel, Joel Dütschler, Marius König et al. · Alimentary Pharmacology & Therapeutics · 2023 · 11 citations

Veterinary Medicine, Immunology, Pharmacotherapy +17

Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease

Simon Woelfel, Joel Dütschler, Daniel Junker et al. · Vaccines · 2024 · 10 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

<scp>XBB</scp>.1.5‐Adapted <scp>COVID</scp>‐19 <scp>mRNA</scp> Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the <scp>SARS</scp>‐<scp>CoV</scp>‐2 <scp>JN</scp>.1 Variant in Patients With Inflammatory Bowel Disease

Simon Woelfel, Joel Dütschler, Daniel Junker et al. · Alimentary Pharmacology & Therapeutics · 2024 · 10 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17